Logo-joddd

Visual Abstract

JODDD now with visual abstracts. Authors can now add a visual abstract to their submission.

Platinum* Open Access

*This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central.

  Indexing & Abstracting

Following

Social media
J Dent Res Dent Clin Dent Prospects. 2021;15(3): 219-225. doi: 10.34172/joddd.2021.036
PMID: 34712414        PMCID: PMC8538146

Reviews

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

Fatemeh Atashi 1 ORCID, Nafiseh Vahed 2, Parya Emamverdizadeh 3 * ORCID, Shirin Fattahi 3, Ladan Paya 3

Cited by CrossRef: 22

1- Dorna D, Paluszczak J. Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers. J Cancer Res Clin Oncol. 2023;149(14):13417 [Crossref]
2- Vincent-Chong V. Editorial of Special Issue “Oral Cancer: From Pathophysiology to Novel Therapeutic Approaches”. Biomedicines. 2023;11(10):2748 [Crossref]
3- Khamaikawin W, Locharoenrat K. Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line. Artificial Cells, Nanomedicine, and Biotechnology. 2023;51(1):148 [Crossref]
4- Belnap C, Divis T, Kingsley K, Howard K. Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance. IJMS. 2024;25(4):2167 [Crossref]
5- Zhang X, Sun K, Gan R, Yan Y, Zhang C, Zheng D, Lu Y. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. BMC Cancer. 2024;24(1) [Crossref]
6- Zhu Y, Zhou X, Yao Z. A mini-review: Advances in plant-derived extracellular vesicles as nano-delivery systems for tumour therapy. Front Bioeng Biotechnol. 2022;10 [Crossref]
7- Lin C, Yu C, Lee T, Chuang J, Han K, Lin C, Huang W, Chen J, Chen C, Lin M, Lee C. Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Phytomedicine. 2023;111:154655 [Crossref]
8- Pang X, Li J, Liu Z, Chen Q, Chen W, Zhang X, Luo G, Shang Z. Targeted Elimination of the Oral Pathogen to Overcome Chemoresistance of Oral Squamous Cell Carcinoma by Biologically Derived Nanotherapeutics. ACS Nano. 2024;18(46):31794 [Crossref]
9- DEMİRAY A, KARAGÜR E, AKÇA H, TOKGÜN O, DEMİRAY A, BİR F. Baş boyun kanserli hastalarda tek gen polimorfizmi ile sisplatin ve 5-FU tedavisine yanıt arasındaki ilişki. 2023;14(3):414 [Crossref]
10- Campagna R, Belloni A, Pozzi V, Salvucci A, Notarstefano V, Togni L, Mascitti M, Sartini D, Giorgini E, Salvolini E, Santarelli A, Lo Muzio L, Emanuelli M. Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines. IJMS. 2022;24(1):338 [Crossref]
11- Zhao Y, Ye X, Xiong Z, Ihsan A, Ares I, Martínez M, Lopez-Torres B, Martínez-Larrañaga M, Anadón A, Wang X, Martínez M. Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells. Metabolites. 2023;13(7):796 [Crossref]
12- Pawlicka M, Gumbarewicz E, Błaszczak E, Stepulak A. Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers. Cancers. 2024;16(7):1354 [Crossref]
13- Anup N, Gadeval A, Ramdas Mule S, Gupta T, Kumar Tekade R. Plasmonic laser-responsive BioDissolve 3D-printed graphene@cisplatin-implant for prevention of post-surgical relapse of oral cancer. International Journal of Pharmaceutics. 2024;657:124123 [Crossref]
14- Acharya S, Shai S, Choon Y, Gunardi I, Hartanto F, Kadir K, Roychoudhury A, Amtha R, Vincent-Chong V. Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges. Biomedicines. 2024;12(9):2111 [Crossref]
15- Cui Y, Liu J, Liu L, Ma X, Gui Y, Liu H, Zhao W. m6A-modified circFOXK2 targets GLUT1 to accelerate oral squamous cell carcinoma aerobic glycolysis. Cancer Gene Ther. 2023;30(1):163 [Crossref]
16- Jamshidi S, Tavangar M, Shojaei S, Taherkhani A, Hashmi A. Malignant Transformation of Normal Oral Tissue to Dysplasia and Early Oral Squamous Cell Carcinoma: An In Silico Transcriptomics Approach. Analytical Cellular Pathology. 2024;2024(1) [Crossref]
17- Yu B, Kruse N, Howard K, Kingsley K. Downstream Target Analysis for miR-365 among Oral Squamous Cell Carcinomas Reveals Differential Associations with Chemoresistance. Life. 2024;14(6):741 [Crossref]
18- Starska-Kowarska K. Role of Mesenchymal Stem/Stromal Cells in Head and Neck Cancer—Regulatory Mechanisms of Tumorigenic and Immune Activity, Chemotherapy Resistance, and Therapeutic Benefits of Stromal Cell-Based Pharmacological Strategies. Cells. 2024;13(15):1270 [Crossref]
19- Zhang S, Zhang L, Lu H, Yao Y, Liu X, Hou J. A cuproptosis and copper metabolism–related gene prognostic index for head and neck squamous cell carcinoma. Front Oncol. 2022;12 [Crossref]
20- Basnayake B, Leo P, Rao S, Vasani S, Kenny L, Haass N, Punyadeera C. Head and neck cancer patient-derived tumouroid cultures: opportunities and challenges. Br J Cancer. 2023;128(10):1807 [Crossref]
21- Kijowska J, Grzegorczyk J, Gliwa K, Jędras A, Sitarz M. Epidemiology, Diagnostics, and Therapy of Oral Cancer—Update Review. Cancers. 2024;16(18):3156 [Crossref]

Featured Prospective Highlight

A novel technique for the impression, model and provisionalization of pinlay
J Dent Res Dent Clin Dent Prospects. 2018;12(1):77-81